Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04967248
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2021-07-08
Brief Title:
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women and Men With HRHER2- Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation After Disease Progression Following Endocrine Therapy as Monotherapy in the Real-world Setting
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CBYL719C2404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None